Research status of miR-135b in malignant tumors of the digestive system
10.13699/j.cnki.1001-6821.2024.18.029
- VernacularTitle:miR-135b在消化系统恶性肿瘤中的研究现状
- Author:
Yu-Jie HE
1
;
Jia CHEN
;
Qi XIA
;
Wen CHEN
;
Pei-Hao YIN
Author Information
1. 成都中医药大学医学与生命科学学院,四川成都 610075
- Keywords:
microRNA;
microRNA-135b;
tumors of the digestive system
- From:
The Chinese Journal of Clinical Pharmacology
2024;40(18):2747-2751
- CountryChina
- Language:Chinese
-
Abstract:
MicroRNAs(microRNAs,miRNAs)are a class of endogenous,single-stranded,short and highly conserved non-coding RNAs.miR-135b,as a member of miRNAs,is aberrantly expressed in digestive malignancies.Its mechanism of action involves a variety of target genes and participates in tumorigenesis and development by regulating cell proliferation,metastasis,and drug resistance.Clinical studies have shown that high expression of miR-135b is associated with poor patient prognosis and decreased survival.As a potential biomarker,miR-135b may be useful in the diagnosis,prognostic assessment,and therapeutic monitoring of malignant tumors of the digestive system.Therefore,miR-135b and its regulated pathways may become future therapeutic targets and provide new ideas for the treatment and management of tumor patients.